Tryp Therapeutics Announces Listing On OTCQB
LA JOLLA, California – Tryp Therapeutics (CSE: TRYP) a pharmaceutical company focused on identifying and developing clinical-stage compounds for diseases with high unmet medical needs, announced today that it has submitted its application for a listing to the OTCQB® Venture Market (“OTCQB”). Their press statement follows:
The Financial Industry Regulatory Authority or FINRA has accepted the Company’s Form 211, which qualifies the Company’s shares to trade in the United States on the OTC Pink Market under the symbol “TRYPF”. The Company has also applied to the Depository Trust Company (“DTC”) for DTC eligibility, which would greatly simplify the process of trading the Company’s common shares. The Company will continue to trade on the Canadian Securities Exchange (“CSE”) under its existing symbol “TRYP.CN”.
The OTCQB Venture Market, operated by OTC Markets Group Inc., is designed for developing and entrepreneurial companies in the U.S. and abroad. Companies must be current in their financial reporting and undergo an annual verification and management certification process, including meeting a minimum bid price and other financial conditions. With more compliance and quality standards, the OTCQB provides investors improved visibility to enhance trading decisions. The OTCQB is recognized by the Securities and Exchange Commission as an established public market providing public information for analysis and value of securities.
Jim Kuo, CEO of the Company commented, “We are pleased to have initiated the listing process of our common shares on the OTCQB. This move allows Tryp to access a broader range of institutional and retail investors in the U.S. as we develop our drug candidates to treat fibromyalgia and eating disorders.”
The listing of the Company’s common shares on the OTCQB remains subject to the approval of the OTCQB and the satisfaction of applicable listing requirements. As more information becomes available, the Company will keep its shareholders up-to-date on the status of the application.
Certain information in this news release, including statements relating to the anticipated closing date of the Placement, constitutes forward-looking information. In some cases, but not necessarily in all cases, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “targets”, “expects” or “does not expect”, “is expected”, “an opportunity exists”, “is positioned”, “estimates”, “intends”, “assumes”, “anticipates” or “does not anticipate” or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might”, “will” or “will be taken”, “occur” or “be achieved”. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances contain forward-looking information. Statements containing forward-looking information are not historical facts but instead represent management’s expectations, estimates and projections regarding future events.
Forward-looking information is necessarily based on a number of opinions, assumptions and estimates that, while considered reasonable by Tryp as of the date of this news release, are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking information, including but not limited to the factors described in greater detail in the “Risk Factors” section of Tryp’s final prospectus available at www.sedar.com. These factors are not intended to represent a complete list of the factors that could affect Tryp; however, these factors should be considered carefully. There can be no assurance that such estimates and assumptions will prove to be correct. The forward-looking statements contained in this news release are made as of the date of this news release, and Tryp expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.
Bloomios Reports Q1 2023 Revenue Growth of 30% Sequentially and 84% Year-on-Year to $2.75 Million
LOS ANGELES-- Santa Barbara-based Bloomios, Inc., a white-label and private-label manufacturer and wholesaler of hemp-derived nutraceutical, cosmetics, and pet products, announced its financial results for the first quarter ended March 31, 2023. The company reported ...
BREAKING: Trulieve Disciplined for Worker Death; Announces Exit from Competitive California & Massachusetts Markets
LOS ANGELES–Trulieve, a prominent cannabis company, has recently found itself embroiled in a distressing incident. In Massachusetts, a tragic workplace accident resulted in the death of one of Trulieve's employees. The company has since faced ...
Minnesota Legalizes Recreational Cannabis, Expanding Market and Tax Revenue
MINNESOTA. - Governor Tim Walz of Minnesota has signed into law a bill legalizing the recreational use of cannabis, making Minnesota the 23rd state in the U.S. to do so. The legislation, known as HF ...